Skip to main content
. 2019 Sep 6;22(5):232–239. doi: 10.14744/AnatolJCardiol.2019.83710

Table 2.

Trimetazidine and CoQ10 enhanced nuclear Nrf2 expression and suppressed the release of cyto-c into cytosol in cisplatin-treated cells

Factor Control Cisplatin Cisplatin+TMZ Cisplatin+CoQ10 Cisplatin+TMZ+CoQ10
Nrf2/Lamin A 1±0.17 0.41±0.09*** 0.6±0.07# 0.63±0.1# 0.87±0.06###$
Cyto-c/GAPDH 1±0.29 17.55±2.94*** 10.76±1.35## 9.65±1.78## 6.71±1.02###$
Nrf2/GAPDH 1±0.15 1.23±0.12 1±0.16 1.06±0.07 0.91±0.19
Cyto-c/COX IV 1±0.22 0.24±0.07*** 0.47±0.05# 0.56±0.11## 0.65±0.12###$
***

P<0.001 as compared with control;

#

P<0.05,

##

P<0.01, and

###

P<0.001 as compared with cisplatin-treated cells;

$

P<0.05 as compared with TMZ or CoQ10-pretreated cells.

TMZ - trimetazidine; CoQ10 - coenzyme Q10